EudraCT Number: 2016-000869-23 Sponsor Protocol Number: Start Date: 2017-03-17
Sponsor Name: The Institute of Cancer Research
Full Title: Targeting cancer care with the use of genetic profiling
Medical condition: Prostate Cancer
Disease: Version SOC Term Classification Code Term Level
19.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10062904 Hormone-refractory prostate cancer PT
Population Age: Adults, Elderly Gender: Male
Trial protocol: GB (GB - no longer in EU/EEA)
Trial results: (No results available)
EudraCT Number: 2019-000702-30 Sponsor Protocol Number: 18.021 Start Date: 2019-10-30
Sponsor Name: Odense University Hospital
Full Title: Fibromyalgia and Naltrexone: The FINAL study
Medical condition: Fibromyalgia
Disease: Version SOC Term Classification Code Term Level
20.0 10028395 - Musculoskeletal and connective tissue disorders 10048439 Fibromyalgia PT
Population Age: Adults Gender: Female
Trial protocol: DK (Ongoing)
Trial results: (No results available)
EudraCT Number: 2017-004506-18 Sponsor Protocol Number: LYMRIT-37-07 Start Date: 2018-06-13
Sponsor Name: Nordic Nanovector ASA
Full Title: A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1)
Medical condition: Follicular lymphoma
Disease: Version SOC Term Classification Code Term Level
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10029547 Non-Hodgkin's lymphoma PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NO (Ongoing)
Trial results: (No results available)
EudraCT Number: 2019-003461-17 Sponsor Protocol Number: 71272 Start Date: 2020-01-07
Sponsor Name: Amsterdam UMC, location VUmc
Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF)
Medical condition: Heart failure with preserved ejection fraction
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2018-003446-16 Sponsor Protocol Number: ATX-ME-001 Start Date: 2019-05-10
Sponsor Name: Achilles Therapeutics Limited
Full Title: An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with metastatic or recurrent melanoma.
Medical condition: Metastatic or recurrent melanoma
Disease: Version SOC Term Classification Code Term Level
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10025650 Malignant melanoma PT
21.1 100000004865 10025651 Malignant melanoma excision LLT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10025652 Malignant melanoma in situ PT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10025670 Malignant melanoma stage III PT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10025671 Malignant melanoma stage IV PT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10053571 Melanoma LLT
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10027148 Melanoma in situ LLT
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10027150 Melanoma malignant LLT
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10066600 Melanoma recurrent PT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10027480 Metastatic malignant melanoma PT
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10027481 Metastatic melanoma LLT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10029488 Nodular melanoma PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA)
Trial results: (No results available)
EudraCT Number: 2018-004081-34 Sponsor Protocol Number: V.000369 Start Date: 2019-09-16
Sponsor Name:
Full Title: The effect of oxytocin on patient-physician relationships: a placebo controlled study
Medical condition: Healthy individuals
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2018-004148-53 Sponsor Protocol Number: M18ICR Start Date: 2019-03-19
Sponsor Name: NKI-AVL
Full Title: ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736)
Medical condition: Metastatic urothelial carcinoma patients or patients with irresectable disease who were previously treated with chemotherapy - or are cisplatin-ineligible - and have progressed during or after trea...
Disease: Version SOC Term Classification Code Term Level
20.0 100000004864 10022880 Invasive bladder cancer stage IV LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2017-003958-16 Sponsor Protocol Number: NL63056.018.17 Start Date: 2018-08-10
Sponsor Name: Academic Medical Center, University of Amsterdam
Full Title: Effect of Reslizumab on small airways in asthma. RESSAPEA
Medical condition: 1. Patients with severe eosinophilic asthma
Disease: Version SOC Term Classification Code Term Level
20.0 100000004855 10068462 Eosinophilic asthma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2018-002564-10 Sponsor Protocol Number: AP-CL-OTHER-PI-12868 Start Date: 2019-04-23
Sponsor Name: Universitair Medisch Centrum Groningen
Full Title: Short-term safety, efficacy and mode of action of apremilast in mild to moderate cutaneous pemphigoid: a phase IIa open label single arm study.
Medical condition: Pemphigoid
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2018-003476-12 Sponsor Protocol Number: UMCU-VASC-CO-002 Start Date: 2019-09-12
Sponsor Name: University Medical Center Utrecht
Full Title: A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of evolocumab added to standard lipid-lowering therapy on fasting and post fat load lipids in pa...
Medical condition: Familial Dysbetalipoproteinemia
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
Medical Conditions
Sponsors and Collaborators
Drug Interventions